Journal of

Clinical Gastroenterology and TreatmentISSN: 2469-584X

Editorial Board

Bo Jin

Professor of Medicine

Department of Gastroenterology

The 309th Hospital of the People's Liberation Army

Beijing, China

Dr. Bo Jin, MD, PhD is a professor and chief physician of the Department of Gastroenterology, the 309thHospital of Chinese People's Liberation Army, and Adjunct Professor of the Second Military Medical University of Chinese People's Liberation Army. Dr. Jin has published more than 50 papers in national or international scientific journals. He is also the Chapter Author of several biomedical bibliographies. Dr. Jin is an international recognized expert in gastroenterology, hepatology and immunology. He is the editorial board member of 10 international biomedical journals. He is an active reviewer of more than 10 international biomedical journals, e.g. Clinical Gastroenterology and


Dr. Bo Jin, MD, PhD is a professor and chief physician of the Department of Gastroenterology, the 309thHospital of Chinese People's Liberation Army, and Adjunct Professor of the Second Military Medical University of Chinese People's Liberation Army. Dr. Jin has published more than 50 papers in national or international scientific journals. He is also the Chapter Author of several biomedical bibliographies. Dr. Jin is an international recognized expert in gastroenterology, hepatology and immunology. He is the editorial board member of 10 international biomedical journals. He is an active reviewer of more than 10 international biomedical journals, e.g. Clinical Gastroenterology and Hepatology, Immunology, and World Journal of Gastroenterology et al. His research interests include the development of double-stranded RNA adjuvanted immunotherapy and therapeutic vaccine for cancer and viral infections, experimental intervention of liver fibrosis. Dr. Jin was awarded an MD from the Second Military Medical University of China, an MS and a PhD from the Chinese People's Liberation Army Medical School. He completed his postdoctoral training at the National Institutes of Health, USA and Faculty of Medicine of University of Toyama, Japan, and was awarded the Fellow's Awards for Research Excellence from the National Institutes of Health, USA.



Xiaofa Qin

Founder and President

GI Biopharma Inc

Westfield

USA

Dr. Xiaofa Qin obtained his MD, PhD in Beijing Medial University, Beijing, China then becamea lecturer and associate professor there. Later, he came to the United States and engaged in medical research as a postdoc, research instructor and assistant professor consecutively in Louisiana State University (LSU) Medical Center in Shreveport, University of Cincinnati college of Medicine, and University of Medicine and Dentistry of New Jersey (UMDNJ)/Rutgers (merged in 2013)-New Jersey Medical School. He brings forward a theory that impaired inactivation of pancreatic digestive proteasesdue to reduction of certain kinds of gut bacteria along with the improved hygiene and inhibition by


Dr. Xiaofa Qin obtained his MD, PhD in Beijing Medial University, Beijing, China then becamea lecturer and associate professor there. Later, he came to the United States and engaged in medical research as a postdoc, research instructor and assistant professor consecutively in Louisiana State University (LSU) Medical Center in Shreveport, University of Cincinnati college of Medicine, and University of Medicine and Dentistry of New Jersey (UMDNJ)/Rutgers (merged in 2013)-New Jersey Medical School. He brings forward a theory that impaired inactivation of pancreatic digestive proteasesdue to reduction of certain kinds of gut bacteria along with the improved hygiene and inhibition by some dietary chemicals may have played a critical role in inflammatory bowel disease (IBD, including ulcerative colitis and Crohn's disease) and possibly multiple other autoimmune, allergic and metabolic diseases that emerged and dramatically increased in modern society, as the result of damage of gut barrier and increased infiltration of bacterial and dietary components. Recently, he founded GI Biopharma Inc aiming at developing some new treatments for these diseases. His Research Interest is The association among pancreatic proteases, gut microbiota, dietary chemicals, and diseases like inflammatory bowel disease (ulcerative colitis and Crohn's disease), etc.



Anil Mishra

Professor

Section of Pulmonary Diseases

Tulane School of Medicine

New Orleans

USA

Dr. Anil Mishra, PhD is Professor of Medicine and Endowed Chair, Edward G. Schlieder Educational Foundationin the Section of Pulmonary Diseases at Tulane School of Medicine, New Orleans, LA. He is also the Director ofEosinophilic Disorder Center at Tulane School of Medicine, New Orleans, LA. Dr. Mishra had an outstanding background, beginning with his distinguished education at Rajasthan University, Jaipur, India where he graduated with Bachelor of Science. Having excelled in science education, he then undertook PhD training at Kanpur University, Kanpur, India. His PhD studies primarily focused on the physiological function of the caudal neurosecretory gland of fish. Soon


Dr. Anil Mishra, PhD is Professor of Medicine and Endowed Chair, Edward G. Schlieder Educational Foundationin the Section of Pulmonary Diseases at Tulane School of Medicine, New Orleans, LA. He is also the Director ofEosinophilic Disorder Center at Tulane School of Medicine, New Orleans, LA. Dr. Mishra had an outstanding background, beginning with his distinguished education at Rajasthan University, Jaipur, India where he graduated with Bachelor of Science. Having excelled in science education, he then undertook PhD training at Kanpur University, Kanpur, India. His PhD studies primarily focused on the physiological function of the caudal neurosecretory gland of fish. Soon after completing his graduate training Dr. Mishra did postdoctoral training in the prestigious Institute of Toxicology, Lucknow, India and further at GSF Institute of Inhalation at Munchen, Germany.



Haruhiko Sugimura

Professor and Chairman

Department of Tumor Pathology

Hamamatsu University School of Medicine

Shizuoka, Japan

Dr. Haruhiko Sugimura is a Professor and Chairman of Department of Tumor Pathology in Hamamatsu University School of Medicine. Dr. Sugimura has a membership in American Association for Cancer Research, American Association for Advancement of Science, Japanese Society of Pathology, Japanese Association of Cancer Research, Japanese Gastric Cancer Society. He is an Editorial Board member of Pathology International, Cancer Science, Gastric Cancer, World Journal of Gastroenterology, World Journal of Gastroenterological Oncology, Journal of Cancer Research and Clinical Oncology (Germany). His Specialties includes Investigative and diagnostic pathology, Molecular Epidemiology, Organs: GI tract and lung.


Dr. Haruhiko Sugimura is a Professor and Chairman of Department of Tumor Pathology in Hamamatsu University School of Medicine. Dr. Sugimura has a membership in American Association for Cancer Research, American Association for Advancement of Science, Japanese Society of Pathology, Japanese Association of Cancer Research, Japanese Gastric Cancer Society. He is an Editorial Board member of Pathology International, Cancer Science, Gastric Cancer, World Journal of Gastroenterology, World Journal of Gastroenterological Oncology, Journal of Cancer Research and Clinical Oncology (Germany). His Specialties includes Investigative and diagnostic pathology, Molecular Epidemiology, Organs: GI tract and lung.



Yoshihiro Moriwaki

Chief of Department of Surgery and Educational Center

Unnan City Hospital

Japan

Dr. Yoshihiro Moriwaki entered Yokohama City University School of Medicine in April 1980. He graduated in March 1987 and entered a postgraduate course of Yokohama City University in April 1987. In March 1991 Dr. Yoshihiro Moriwaki received a degree of physical doctor and he joined in the Department of Critical Care and Emergency Medicine, Yokohama City University School of Medicine from May 1996 as the assistant. In April 2007 Dr. Yoshihiro Moriwaki was appointed as an Associate Professor in the Critical Care and Emergency Center, Yokohama City University Medical Center. From January 2012 Dr. Yoshihiro Moriwaki is working as Chief


Dr. Yoshihiro Moriwaki entered Yokohama City University School of Medicine in April 1980. He graduated in March 1987 and entered a postgraduate course of Yokohama City University in April 1987. In March 1991 Dr. Yoshihiro Moriwaki received a degree of physical doctor and he joined in the Department of Critical Care and Emergency Medicine, Yokohama City University School of Medicine from May 1996 as the assistant. In April 2007 Dr. Yoshihiro Moriwaki was appointed as an Associate Professor in the Critical Care and Emergency Center, Yokohama City University Medical Center. From January 2012 Dr. Yoshihiro Moriwaki is working as Chief of Department of Surgery and General Medicine at Unnan City Hospital, Japan. Dr. Yoshihiro Moriwaki research interests includes Gastroenterology, Gastroenterological surgery General Surgery, Trauma surgery, Acute care surgery, Gastroenterology, Emergency Medicine, Critical Care.



Eleazar Chaib

Director

Liver Transplantation and Surgery Division

Department of Gastroenterology

University of Sao Paulo

Brazil

Tel: 55-11-97217-1359

Dr. Eleazar Chaib is Director of Department of Gastroenterology at University of Sao Paulo in Brazil. Dr. Chaib received his Ph.D from University of Sao Paulo School of Medicine. He is a member of the Transplantation Society, Brazilian Society of Videolaparoscopy, International Hepato - Pancreato Biliary Association. He is a Fellow of the Royal College of Surgeons - England (FRCS), Fellow of the Royal Society of Medicine - England (FRSM) and Member of American Association of Clinical Anatomist (AACA). His Research interests include Hepato - Pancreato - Biliary Surgery and Anatomy, Liver and Pancreas Transplantation.


Dr. Eleazar Chaib is Director of Department of Gastroenterology at University of Sao Paulo in Brazil. Dr. Chaib received his Ph.D from University of Sao Paulo School of Medicine. He is a member of the Transplantation Society, Brazilian Society of Videolaparoscopy, International Hepato - Pancreato Biliary Association. He is a Fellow of the Royal College of Surgeons - England (FRCS), Fellow of the Royal Society of Medicine - England (FRSM) and Member of American Association of Clinical Anatomist (AACA). His Research interests include Hepato - Pancreato - Biliary Surgery and Anatomy, Liver and Pancreas Transplantation.



Aaron Lerner

Head

Unit of Pediatric Gastroenterology and Nutrition

Carmel Medical Center

Haifa, Israel

Dr. Aaron Lerner is a Head/Professor of Unit of Pediatric Gastroenterology and Nutrition in Carmel Medical Center,Israel. Dr. Lerner is also an Associate Professor of Department of Medicine in Israel Institute of Technology, Israel. He has published 190 peer-reviewed articles. His research interest includes Mucosal immunology, apoptosis, cancerogenesis, autoimmunity, diagnostic serology, celiac disease, inflammatory bowel diseases, nutritional deficiencies, iron absorption, industrial food additives.


Dr. Aaron Lerner is a Head/Professor of Unit of Pediatric Gastroenterology and Nutrition in Carmel Medical Center,Israel. Dr. Lerner is also an Associate Professor of Department of Medicine in Israel Institute of Technology, Israel. He has published 190 peer-reviewed articles. His research interest includes Mucosal immunology, apoptosis, cancerogenesis, autoimmunity, diagnostic serology, celiac disease, inflammatory bowel diseases, nutritional deficiencies, iron absorption, industrial food additives.



Yongzhan Nie

Professor/Vice director

Department of Gastroenterology

Xijing Hospital

Xi'an, China

Tel: 86-29-84771620

Dr. Yongzhan Nie is a professor of Gastroenterology, vice director of the State key Laboratory of Cancer biology and the Department of Gastroenterology, Xijing Hospital. Dr. Nie is the member of standing committee of the Society of Tumor Metastasis, Chinese Anti-Cancer Association; member of committee for the Chinese Human Proteome Organization; member of the Youth committee of the Chinese Society of Gastroenterology; member of the American Association of Cancer Research, and the American Association for the Study of Liver Diseases. Dr. Nie is a member on the editor board of Proteomics Clinical Applications. Currently Dr. Nie researches focus on the


Dr. Yongzhan Nie is a professor of Gastroenterology, vice director of the State key Laboratory of Cancer biology and the Department of Gastroenterology, Xijing Hospital. Dr. Nie is the member of standing committee of the Society of Tumor Metastasis, Chinese Anti-Cancer Association; member of committee for the Chinese Human Proteome Organization; member of the Youth committee of the Chinese Society of Gastroenterology; member of the American Association of Cancer Research, and the American Association for the Study of Liver Diseases. Dr. Nie is a member on the editor board of Proteomics Clinical Applications. Currently Dr. Nie researches focus on the molecular mechanism of metastasis and screening for biomarkers in gastric cancer. As a first or corresponding author he has published more than 15 papers as first author or corresponding author on Nature Cell Biology, PLoS Genetics, Journal of Hepatology, Oncogene, Molecular & cellular Biology, Journal of Biological chemistry, Journal of Virology etc.



Mark David Noar

Professor

Department of Gastroenterology

Guangzhou Medical University

Guangzhou

China

Dr. Mark D. Noar, is a Gastroenterologist and Therapeutic Endoscopist, who specializes in the advanced treatment of Digestive Diseases. He completed his training in Gastroenterology at Downstate Medical Center/Brooklyn VA, in Brooklyn, New York. His training in Therapeutic Endoscopy was under the direction of Dr. Nib Soehendra, at the University Hospital in Hamburg, Germany. He received his M.P.H. in Tropical Medicine and International Health from Tulane University. Dr. Noar has numerous awards, publications and presentations to his credit, as well as inventions in Medical Simulation, Endoscopic Biliary Instrumentation, and Electrogastrography. He currently serves as the CEO and Medical director


Dr. Mark D. Noar, is a Gastroenterologist and Therapeutic Endoscopist, who specializes in the advanced treatment of Digestive Diseases. He completed his training in Gastroenterology at Downstate Medical Center/Brooklyn VA, in Brooklyn, New York. His training in Therapeutic Endoscopy was under the direction of Dr. Nib Soehendra, at the University Hospital in Hamburg, Germany. He received his M.P.H. in Tropical Medicine and International Health from Tulane University. Dr. Noar has numerous awards, publications and presentations to his credit, as well as inventions in Medical Simulation, Endoscopic Biliary Instrumentation, and Electrogastrography. He currently serves as the CEO and Medical director of a large academic-style, state-of-the-art, subspecialty private practice specializing in Digestive Diseases, with a special emphasis on the treatment and non-surgical correction of GERD or reflux disease, fecal incontinence, advanced endoscopic techniques, and motility of the entire gastrointestinal tract. The practice and the associated outpatient surgery center are both accredited by the JCAHO, AAAHC and Medicare, and as such are highly committed to quality and patient satisfaction.



Abdurrahman Kadayifci

Professor

Division of Gastroenterology,

University of Gaziantep

Gaziantep, Turkey

Tel: +1-617-919-9934

Dr. Abdurrahman Kadayifci was graduated from Hacettepe School of Medicine in 1989. Between 1989-1996, he did his residency and then gastroenterology fellowship at the same university. He was appointed for an Assoc. Proff. position in University of Gaziantep at year of 2000. He established the Division of Gastroenterology and a modern well equipped Endoscopy Unit. He chaired the division for 5 years. With a grant of ESGE, he studied 2 months at Hopital Edouard Harriot, Gastroenterology Unit, Lyon, France. He was appointed as the Professor of Medicine in the year of 2002. He worked as a Postdoc Scholar at


Dr. Abdurrahman Kadayifci was graduated from Hacettepe School of Medicine in 1989. Between 1989-1996, he did his residency and then gastroenterology fellowship at the same university. He was appointed for an Assoc. Proff. position in University of Gaziantep at year of 2000. He established the Division of Gastroenterology and a modern well equipped Endoscopy Unit. He chaired the division for 5 years. With a grant of ESGE, he studied 2 months at Hopital Edouard Harriot, Gastroenterology Unit, Lyon, France. He was appointed as the Professor of Medicine in the year of 2002. He worked as a Postdoc Scholar at the Hepatology Unit of UCSF for 1 year in 2005-2006. Between 2002-2013, he was appointed two terms as the Vice President of the University and two terms as the Dean of Medical Faculty. He has been working at Division of Gastroenterology, Mass General Hospital, Harvard Medical School in Boston as a Visiting Professor and Research Scholar since July of 2013. He has more than 100 publications on SCI-E journals, and more than 900 citations to his papers. He is the editor of 9 books in Medicine and has chapters in well-known medical textbooks. He has the European Board of Gastroenterology and Hepatology.



Atsushi Mitsunaga

Associate Professor

Department of Endoscopy

Yachiyo Medical Center

Tokyo Women's Medical University

Tokyo, Japan

After 1984, I have been involved in the diagnosis treatment of upper gastrointestinal disease with endoscopy. What I first dealt with was a diagnosis of gastric submucosal tumor using endoscopic ultrasonography. At that time, there was no effective qualitative diagnostic method for gastrointestinal submucosal tumor and by clarifying that endoscopic ultrasonography (EUS) was an effective examination method, I received doctorate with the thesis with that results. In 1987, I was involved in the treatment of early gastrointestinal cancer (especially early gastric cancer) using endoscopy. Through the results of the treatments, I clarified that no difference was found between the surgical


After 1984, I have been involved in the diagnosis treatment of upper gastrointestinal disease with endoscopy. What I first dealt with was a diagnosis of gastric submucosal tumor using endoscopic ultrasonography. At that time, there was no effective qualitative diagnostic method for gastrointestinal submucosal tumor and by clarifying that endoscopic ultrasonography (EUS) was an effective examination method, I received doctorate with the thesis with that results. In 1987, I was involved in the treatment of early gastrointestinal cancer (especially early gastric cancer) using endoscopy. Through the results of the treatments, I clarified that no difference was found between the surgical treatment and endoscopic treatment in the prognosis of the early stage cancer if it does not show the possibility of lymph node metastasis. Furthermore, endoscopic treatment is a safe treatment method for the early stage cancer for the seniors and I publicized through academic society's meetings and thesis that endoscopic treatment, which has great QOL, is a critical treatment method for early stage gastrointestinal cancer in Japan, where population of senior citizen is growing rapidly. Also, I cooperated in the development of bio-polar snare which is a brand new type of snare, a device used in endoscopic treatment, with Zeon Medical Inc, and it was implemented clinically. I publicized the research results in specialized academic society meetings and thesis in Japan as well as abroad. When determining whether endoscopic submucosal dissection (ESD) is an appropriate treatment or not, it is necessary to diagnose an accurate invasion depth, and EUS is widely used as a diagnosis method. However, the accuracy has been low with 70 to 80% so it is not at the satisfactory level. On the other hand, a recent study has done invasion depth diagnosis using EUS from a new perspective and got the accuracy around 95%. I have reported the results in academic society meetings in Japan and abroad and wrote a thesis on it. 1)Presently, I have been examining characteristics of the metachronous gastric cancer after the Helicobacter pylori eradication based on case studies 2) and establishing the surveillance method of metachronous gastric cancer after the Helicobacter pylori eradication.



Florin Burada

Associate Professor

Department of Medical Genetics

University of Medicine and Pharmacy of Craiova

Romania

Dr. Florin Burada is an Associate Professor of Department of Medical Genetics at University of Medicine and Pharmacy of Craiova, Romania. Dr. Burada is a Research member in Research Center of Gastroenterology and Hepatology and Specialist physician in Medical Genetics at physician in Medical Genetics and Emergency Clinical County Hospital Craiova. His Managment Activities include: Head of Medical Genetics Department, University of Medicine and Pharmacy Craiova, Romania, Head of Cytogenetic Laboratory- Human Genomic Laboratory, University of Medicine and Pharmacy Craiova, President - Dolj branch of Romanian Society of Medical Genetics, Member - Coucil of Romanian Society of Medical Genetics,


Dr. Florin Burada is an Associate Professor of Department of Medical Genetics at University of Medicine and Pharmacy of Craiova, Romania. Dr. Burada is a Research member in Research Center of Gastroenterology and Hepatology and Specialist physician in Medical Genetics at physician in Medical Genetics and Emergency Clinical County Hospital Craiova. His Managment Activities include: Head of Medical Genetics Department, University of Medicine and Pharmacy Craiova, Romania, Head of Cytogenetic Laboratory- Human Genomic Laboratory, University of Medicine and Pharmacy Craiova, President - Dolj branch of Romanian Society of Medical Genetics, Member - Coucil of Romanian Society of Medical Genetics, Member - Education Committee of Romanian Society of Medical Genetics.



Toru Ishikawa

General Manager of Gastroenterology

Saiseikai Niigata Daini Hospital

Niigata, Japan

Toru Ishikawa, Ph D, M.D., General Manager of Gastroenterology, Saiseikai Niigata Daini Hospital from 2008 to now. From 1992 to 1993, Ishikawa was a Resident in the Niigata University Hospital, Niigata, Japan. From 1993 to 1994, Ishikawa was a Resident in the Sinrakuen Hospital, Niigata, Japan. From 1994 to 1995, Ishikawa was a medical Staff in the Saiseikai Niigata Daini Hospital, Niigata, Japan. From 1995 to 2002, Ishikawa was a Resident in the the Third Department of Internal Medicine in the Niigata University Hospital, Niigata, Japan. From 2002 to 2007, Ishikawa was a Head Doctor of Gastroenterology, Saiseikai Niigata Daini


Toru Ishikawa, Ph D, M.D., General Manager of Gastroenterology, Saiseikai Niigata Daini Hospital from 2008 to now. From 1992 to 1993, Ishikawa was a Resident in the Niigata University Hospital, Niigata, Japan. From 1993 to 1994, Ishikawa was a Resident in the Sinrakuen Hospital, Niigata, Japan. From 1994 to 1995, Ishikawa was a medical Staff in the Saiseikai Niigata Daini Hospital, Niigata, Japan. From 1995 to 2002, Ishikawa was a Resident in the the Third Department of Internal Medicine in the Niigata University Hospital, Niigata, Japan. From 2002 to 2007, Ishikawa was a Head Doctor of Gastroenterology, Saiseikai Niigata Daini Hospital. My interest Key Words: Hepatocellular carcinoma, Portal hypertension, Hepatitis



Editor-in-chief


ClinMed International Library

3
0
1
0

Articles Published

All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.

Contact our editorial office

Editors' Picks

Can Genetic Testing Provide Information to Develop Customized Nutrigenomic..
Pubmed ID:26225358 | PMC ID:PMC4516390
Acute Ovarian Insufficiency and Uterine Infarction Following Uterine Artery..
Pubmed ID:26523290 | PMC ID:PMC4623578
Challenges of Fertility Sparing Ovarian Surgery Imposed by Krukenberg..
Pubmed ID:26366440 | PMC ID:PMC4563814
Ultra-High Resolution Optical Coherence Tomography Imaging of Unilateral..
Pubmed ID:27398405 | PMC ID:PMC4936830
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant)..
Pubmed ID:29034323 | PMC ID:PMC5638455
Titanates and Titanate-Metal Compounds in Biological Contexts..
Pubmed ID:26430701 | PMC ID:PMC4587770
MyHEART: A Non Randomized Feasibility Study of a Young Adult..
Pubmed ID:28191544 | PMC ID:PMC5300088
Exenatide Effects on Cardiometabolic Risk and Weight in Adolescents..
Pubmed ID:27182560 | PMC ID:PMC4864000
A New Animal Model to Study Endogenous Cardiotonic Steroids and the Progression..
Pubmed ID:26457335 | PMC ID:PMC4599712
Common Genetic Variation in Circadian Rhythm Genes and Risk of..
Pubmed ID:26807442 | PMC ID:PMC4722961
Active Hexose Correlated Compound Activates Immune Function to Decrease..
Pubmed ID:27790645 | PMC ID:PMC5079436
The Extraction, Anticancer Effect, Bioavailability, and..
Pubmed ID:27790646 | PMC ID:PMC5079443
Kyphosis and Sleep Characteristics in Older Persons: The Rancho..
Pubmed ID:28480455 | PMC ID:PMC5419044
Suppression of Experimental Arthritis through AMP-Activated Protein..
Pubmed ID:26120598 | PMC ID:PMC4479345
Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of..
Pubmed ID:27110599 | PMC ID:PMC4841619
Elder Mistreatment and its Subtypes across Different Sociodemographic and..
Pubmed ID:26973979 | PMC ID:PMC4786076
Balance and its Clinical Assessment in Older Adults - A Review..
Pubmed ID:26942231 | PMC ID:PMC4773046
Caregiver Abuse of Chicago Chinese Older Adults in a Community..
Pubmed ID:27606358 | PMC ID:PMC5008847
The Relationship of Older Adults' Physical Pain to Depression and..
Pubmed ID:27642644 | PMC ID:PMC5023019
Sphingosine 1-Phosphate Receptor 2 Regulates the Migration,..
Pubmed ID:27275017 | PMC ID:PMC4888913
Mammary Epithelial Cell Lineage Analysis via the Lyon's Hypothesis..
Pubmed ID:27453956 | PMC ID:PMC4957014
Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell..
Pubmed ID:27570841 | PMC ID:PMC4996274
Long-Term Function, Pain and Medication Use Outcomes of Radiofrequency..
Pubmed ID:26005713 | PMC ID:PMC4440581
Caspase Cleaved Tau in Alzheimer's Disease: A Therapeutic Target..
Pubmed ID:25639474 | PMC ID:PMC4308811
Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?..
Pubmed ID:26550607 | PMC ID:PMC4634668
Differences in ME and CFS Symptomology in Patients with Normal and..
Pubmed ID:28713856 | PMC ID:PMC5510614
Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive..
Pubmed ID:26005715 | PMC ID:PMC4440485
A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1..
Pubmed ID:26688830 | PMC ID:PMC4682050
Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced..
Pubmed ID:26726315 | PMC ID:PMC4697745
Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate..
Pubmed ID:26878064 | PMC ID:PMC4751054
Electron Microscopic Analysis of Silicate and Calcium Particles..
Pubmed ID:27158665 | PMC ID:PMC4858188
Effects of chest physical therapy in patients with non-tuberculous mycobacteria
Pubmed ID:28804763 | PMC ID:PMC5552049
A Community-Based Exercise and Support Group Program Improves Quality..
Pubmed ID:26640827 | PMC ID:PMC4667740
Four Weeks of Balance Training Does Not Affect Ankle Joint Stiffness in Subjects..
Pubmed ID:27642647 | PMC ID:PMC5025258
Social Ecology and Diabetes Self-Management among Pacific Islanders..
Pubmed ID:28736764 | PMC ID:PMC4516390
Examining Characteristics of Hospitalizations in Heart Failure Patients: Results..
Pubmed ID:28736765 | PMC ID:PMC5517048